iCAD Inc (ICAD):企業の財務・戦略的SWOT分析

◆英語タイトル:iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0302
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

iCAD Inc (ICAD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

iCAD Inc (iCAD) is a medical technology company that provides advanced image analysis, radiation therapies and innovative workflow solutions for the early disclosure and treatment of cancers. The company offers cancer detection products and solutions which includes Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. The company also provides Xoft System, a proprietary electronic brachytherapy platform for oncology treatment. The company uses artificial intelligence for its product development. iCAD operated primarily in the US and markets products through direct sales organization, OEM partners, distributors and resellers in the US and abroad. iCAD is headquartered in Nashua, New Hampshire, the US.

iCAD Inc Key Recent Developments

Oct 30,2019: iCAD reports financial and operating results for the third quarter and nine months ended September 30, 2019
Aug 01,2019: iCAD reports second quarter 2019 financial results
May 07,2019: iCAD reports first quarter 2019 financial results
May 06,2019: iCAD names R. Scott Areglado as chief financial officer
Mar 28,2019: iCAD appoints Stacey Stevens as president

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
iCAD Inc – Key Facts
iCAD Inc – Key Employees
iCAD Inc – Key Employee Biographies
iCAD Inc – Major Products and Services
iCAD Inc – History
iCAD Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
iCAD Inc – Business Description
Business Segment: Cancer Detection (Detection)
Overview
Performance
Business Segment: Cancer Therapy (Therapy)
Overview
Performance
iCAD Inc – Corporate Strategy
iCAD Inc – SWOT Analysis
SWOT Analysis – Overview
iCAD Inc – Strengths
iCAD Inc – Weaknesses
iCAD Inc – Opportunities
iCAD Inc – Threats
iCAD Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
iCAD Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
iCAD Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
iCAD Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 30, 2019: iCAD reports financial and operating results for the third quarter and nine months ended September 30, 2019
Aug 01, 2019: iCAD reports second quarter 2019 financial results
May 07, 2019: iCAD reports first quarter 2019 financial results
May 06, 2019: iCAD names R. Scott Areglado as chief financial officer
Mar 28, 2019: iCAD appoints Stacey Stevens as president
Mar 18, 2019: iCAD reports fourth quarter and full-year 2018 financial results
Mar 01, 2019: iCAD to form new alliance for AI breast cancer risk prediction
Dec 27, 2018: iCAD announces CFO transition
Nov 09, 2018: iCAD announces retirement of CEO, Ken Ferry
Sep 26, 2018: Resignation from the Board of Directors of iCAD
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
iCAD Inc, Key Facts
iCAD Inc, Key Employees
iCAD Inc, Key Employee Biographies
iCAD Inc, Major Products and Services
iCAD Inc, History
iCAD Inc, Other Locations
iCAD Inc, Subsidiaries
iCAD Inc, Key Competitors
iCAD Inc, Ratios based on current share price
iCAD Inc, Annual Ratios
iCAD Inc, Annual Ratios (Cont...1)
iCAD Inc, Annual Ratios (Cont...2)
iCAD Inc, Interim Ratios
iCAD Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
iCAD Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
iCAD Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
iCAD Inc, Performance Chart (2014 - 2018)
iCAD Inc, Ratio Charts
iCAD Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
iCAD Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[iCAD Inc (ICAD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務情報
    Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report Summary Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lego AS:企業の戦略的SWOT分析
    Lego AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • N4 Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary N4 Pharma Ltd (n4 Pharma), a subsidiary of N4 Pharma Plc, is a drug reformulation company. The company develops and out licensing of new versions of existing high value drugs with an unmet commercial or medical need. Its proprietary platform technology, Cocrys and Nuvac, focus on improving t …
  • Venn Life Sciences Holdings Plc (VENN):企業の財務・戦略的SWOT分析
    Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology …
  • Korea Midland Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Midland Power Co., Ltd. (Komipo), a subsidiary of Korea Electric Power Corporation, is an electric utility which generates electricity; operates power plants; and provides various energy services. The company produces electricity from bituminous coal, anthracite coal, liquefied natural …
  • Lockheed Martin Corp:企業の戦略・SWOT・財務情報
    Lockheed Martin Corp - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Grupo Herdez SA de CV:企業の戦略・SWOT・財務情報
    Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Dah Chong Hong Holdings Ltd (1828):企業の財務・戦略的SWOT分析
    Dah Chong Hong Holdings Ltd (1828) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Schneider Electric SE (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line includes automation and control products, building management and securit …
  • Cineworld Group Plc:企業の戦略・SWOT・財務分析
    Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report Summary Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Core-Mark Holding Company, Inc. (CORE):企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Symrise AG (SY1):製薬・医療:M&Aディール及び事業提携情報
    Summary Symrise AG (Symrise) offers flavors and fragrances. The company develops, produces and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions for the cosmetics industry. It also provides biofunctional and bioactive ingredients an …
  • University of Pennsylvania:企業のM&A・事業提携・投資動向
    University of Pennsylvania - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pennsylvania Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Diffusion Pharmaceuticals Inc (DFFN):企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Keio University:製薬・医療:M&Aディール及び事業提携情報
    Summary Keio University (Keio) is an educational institution that offers education and research services. The institute provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the fields of law and economics, hum …
  • Autogrill S.p.A.:企業の戦略・SWOT・財務情報
    Autogrill S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Autogrill S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析
    Summary Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The company’s product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM …
  • Sopharma AD (3JR):企業の財務・戦略的SWOT分析
    Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Xiwang Special Steel Company Limited:企業の戦略・SWOT・財務情報
    Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report Summary Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆